Opthea LTD (OPTEY) — 20-F Filings
All 20-F filings from Opthea LTD. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (2)
-
Opthea Scraps Flagship Drug, Pays $20M to Exit Funding Deal
— Sep 15, 2025 Risk: high
Opthea Ltd (OPTEY) reported a significant strategic shift for the fiscal year ended June 30, 2025, following the failure of its sozinibercept Phase 3 trials. Th -
Opthea Ltd Files 20-F for FY2024
— Aug 30, 2024 Risk: medium
Opthea Ltd filed its 20-F for the fiscal year ending June 30, 2024. The filing details its business operations in biological products, specifically focusing on
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX